EMA Conducts Fewer GMP, More GCP and Pharmacovigilance Inspections

The EMA noted a steep decrease in GMP inspections in its annual report for 2017, as well as a hike in inspections for good clinical practices and nearly double the amount of pharmacovigilance inspections than the previous year.
Source: International Pharmaceutical Regulatory Monitor